Alpha Tau Medical 近日宣布,其针对胰腺癌的 Alpha Dart® 技术相关数据,将于2026年消化疾病周上首次以口头报告形式公布。
Alpha Tau Medical 近日宣布,其针对胰腺癌的 Alpha Dart® 技术相关数据,将于2026年消化疾病周上首次以口头报告形式公布。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.